Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

H odgkin transformation of chronic lymphocytic leukemia: I ncidence, outcomes, and comparison to de novo H
Chaffee, Kari G. , Call, Timothy G. , Leis, José F., Macon, William R. , Schwager, Susan M., Ristow, Kay M., Porrata, Luis F. , Rabe, Kari G. , Parikh, Sameer A. , Habermann, Thomas M. , Ding, Wei , Kay, Neil E. , Slager, Susan L. , Shanafelt, Tait D.

American Journal of Hematology | January 10, 2015 | Volume: 90 | Issue: 4 | Pages: 334-338

10.1002/ajh.23939 | PMID 25581025 Get It

Although transformation to Hodgkin lymphoma (HL) is a recognized complication in patients with chronic lymphocytic leukemia (CLL), its incidence, clinical characteristics and outcomes are not well defined. We used the Mayo Clinic CLL and Lymphoma Databases to identify CLL patients who developed biopsy‐proven HL (CLL/HL) on follow‐up, as well as cases of de novo HL (i.e., without prior CLL). Among 3887 CLL patients seen at Mayo Clinic from January 1995 through August 2011, 26 (0.7%) developed HL. In a nested cohort of 2,465 newly diagnosed CLL patients followed prospectively, the incidence of HL was 0.05%/year (10 year risk = 0.5%). The median overall survival (OS) from date of HL diagnosis in patients with CLL/HL was 3.9 years compared to not reached for de novo HL patients ( n = 709) seen during the same time interval ( P < 0.001). The shorter OS of CLL/HL patients persisted after adjusting for differences in age and Ann Arbor stage of disease. The International Prognostic score (IPS) developed for de novo HL stratified prognosis among CLL/HL patients with median survival of not reached, 6.2, 2.4, and 0.3 years ( P = 0.006) for those with IPS scores of ≤2, 3, 4, and ≥5, respectively. In summary, approximately 1 of every 200 CLL patients will develop HL within 10 years. Survival after HL diagnosis in patients with CLL is shorter than de novo HL patients. The IPS for de novo HL may be useful for stratifying survival in CLL/HL patients. Am. J. Hematol. 90:334–338, 2015. © 2015 Wiley Periodicals, Inc.
Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer
Ngamruengphong, Saowanee , Swanson, Kristi M. , Shah, Nilay D. , Wallace, Michael B. , Wallace, Michael B

Gut | January 10, 2015 | Volume: 64 | Issue: 7 | Pages: 1105-1110

10.1136/gutjnl-2014-307475 | PMID 25575893 Get It

Objective Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) allows preoperative tissue confirmation of malignancy, but fear of tumour cell dissemination along the needle track has limited its use. We hypothesised that if tumour cell dissemination occurs with EUS-FNA, survival after complete resection would be impaired. We aimed to evaluate the association of preoperative EUS-FNA with long-term outcomes of patients with resected pancreatic cancer. Design Using the linked Surveillance, Epidemiology, and End Results (SEER)–Medicare data, we identified patients with locoregional pancreatic cancer who underwent curative intent surgery from 1998 to 2009. The patients who received EUS-FNA within the peridiagnostic period were included in the EUS-FNA group. Patients who did not receive EUS evaluation or who underwent EUS without FNA were included in the non-EUS-FNA group. Overall survival and pancreatic cancer-specific survival were compared after controlling for relevant covariates. Results A total of 2034 patients with pancreatic cancer were included (90% pancreatic adenocarcinoma). Of these, 498 (24%) patients were in EUS-FNA group. Patients with multiple comorbidities and more recent diagnosis were more likely to receive EUS-FNA. In multivariate analysis, after controlling for age, race, gender, tumour histology, tumour stage, tumour grade, tumour location, SEER site, year of diagnosis, undergoing percutaneous aspiration/biopsy, Charlson Comorbidity Index, radiation and chemotherapy, EUS-FNA was marginally associated with improved overall survival (HR 0.84, 95% CI 0.72 to 0.99), but did not affect cancer-specific survival (HR 0.87, 95% CI 0.74 to 1.03). Conclusions Preoperative EUS-FNA was not associated with increased risk of mortality. These data suggest that EUS-FNA can be safely performed for the work-up of suspicious pancreatic lesions.
Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis
Bruminhent, Jackrapong , Athas, Deena M., Hess, Bryan , Flomenberg, Phyllis , Bruminhent, Jackrapong

Transplant Infectious Disease | January 9, 2015 | Volume: 17 | Issue: 1 | Pages: 125-128

10.1111/tid.12342 | PMID 25571908 Get It

AbstractWe report a 65‐year‐old heart transplant recipient who presented with conjunctivitis, likely acquired from a family member who worked at a daycare center during an outbreak of conjunctivitis. He developed a severe adenoviral pneumonitis, which was successfully treated with intravenous cidofovir combined with a reduction of immunosuppression.
Technical Modifications in the Repair of Acute Ischemic Posterior Ventricular Septal Defect Without Ventriculotomy
Murashita, Takashi , Greason, Kevin L. , Suri, Rakesh M. , Joyce, David L. , Stulak, John M., Schaff, Hartzell V. , Schaff, Hartzell

Journal of Cardiac Surgery | January 9, 2015 | Volume: 30 | Issue: 3 | Pages: 233-237

10.1111/jocs.12498 | PMID 25571774 Get It

PVAAS: identify variants associated with aberrant splicing from RNA-seq
Wang, Liguo , Nie, Jinfu, Kocher, Jean‐Pierre , Nie, Jinfu J, Wang, Liguo

Bioinformatics | January 9, 2015 | Volume: 31 | Issue: 10 | Pages: 1668-1670

10.1093/bioinformatics/btv001 | PMID 25573917 Get It

Abstract Motivation: RNA-seq has been widely used to study the transcriptome. Comparing to microarray, sequencing-based RNA-seq is able to identify splicing variants and single nucleotide variants in one experiment simultaneously. This provides unique opportunity to detect variants that associated with aberrant splicing. Despite the popularity of RNA-seq, no bioinformatics tool has been developed to leverage this advantage to identify variants associated with aberrant splicing. Results: We have developed PVAAS, a tool to identify single nucleotide variants that associated with aberrant alternative splicing from RNA-seq data. PVAAS works in three steps: (i) identify aberrant splicings; (ii) use user-provided variants or perform variant calling; (iii) assess the significance of association between variants and aberrant splicing events. Availability and implementation: PVAAS is written in Python and C. Source code and a comprehensive user’s manual are freely available at: http://pvaas.sourceforge.net/. Contact: wang.liguo@mayo.edu or kocher.jeanpierre@mayo.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions
Nishimura, Rick A., Warnes, Carole A.

Heart | January 9, 2015 | Volume: 101 | Issue: 6 | Pages: 430-435

10.1136/heartjnl-2014-306500 | PMID 25573983 Get It

The management of women with mechanical heart valves during pregnancy remains difficult and controversial. There is no ideal anticoagulation regimen for this unique population, as there are inherent risks and benefits of each approach for both mother and fetus. There has been limited data available to guide the clinician in the optimal treatment strategy for an individual patient. The AHA/ACC Guidelines for the Management of Patients with Valvular Heart Disease created class recommendations for this population based upon current evidence, which is summarized in this review.
Nanopore-Based Assay for Detection of Methylation in Double-Stranded DNA Fragments
Shim, Jiwook , Humphreys, Gwendolyn I., Nardulli, Ann M., Kosari, Farhad , Vasmatzis, George , Ahlquist, David A. , Myong, Sua , Kim, Young-Hoon , Taylor, William R. , Bashir, Rashid

ACS Nano | January 8, 2015 | Volume: 9 | Issue: 1 | Pages: 290-300

10.1021/nn5045596 | PMID 25569824 Get It

A Five-Year-Old Child with a Subcutaneous Forehead Nodule
Westblade, Lars F. , Fischer, Peter , Haghi, Nina, Schniederjan, Matthew , Pritt, Bobbi S. , Long, John G., Jerris, Robert C. , Garola, Robert E., Pritt, Bobbi S

Pediatric and Developmental Pathology | January 8, 2015 | Volume: 18 | Issue: 2 | Pages: 164-166

10.2350/14-08-1545-cr.1 | PMID 25569144 Get It

We describe a case of a 5-year-old girl with onchocerciasis. The patient was recently adopted from Ethiopia and presented with a firm, raised nodule on the midportion of the forehead. Initially, Langerhans cell histiocytosis with bone involvement was suspected; however, histopathologic analysis of the excised nodule revealed the presence of a young-adult, female Onchocerca volvulus worm. This case exemplifies the importance of recognizing the key morphologic characteristics of adult O. volvulus worms isolated from pediatric patients in nonendemic areas to ensure adroit clinical management.
Diastolic Function in Patients with Hypertrophic Cardiomyopathy: Evaluation Using the Phase-contrast MRI Measurement of Mitral Valve and Pulmonary Vein Flow Velocities
Lee, Sang-Chol, Oh, Jae K. , Kim, Eun Young , Choe, Yeon Hyeon , Kim, Sung Mok , Lee, Sang-Chol, Chang, Sung‐A

Journal of the Korean Society of Magnetic Resonance in Medicine | January 8, 2015 | Volume: 18 | Issue: 4 | Pages: 314

10.13104/jksmrm.2014.18.4.314 Get It

Use of Flattening Filter Free Photon Beams for Off-axis Targets in Conformal Arc Stereotactic Body Radiation Therapy
Serago, Christopher F., Hintenlang, Kathleen, Vallow, Laura A., Peterson, Jennifer , Hintenlang, David E., Buskirk, Steven J., Smith, Ashley A. , Kim, Siyong , Ko, Stephen J. , Heckman, Michael G.

Progress in Medical Physics | January 8, 2015 | Volume: 25 | Issue: 4 | Pages: 288

10.14316/pmp.2014.25.4.288 Get It